Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Non-Current Deffered Revenue (2016 - 2020)

Organogenesis Holdings has reported Non-Current Deffered Revenue over the past 5 years, most recently at $1.1 million for Q3 2020.

  • Quarterly results put Non-Current Deffered Revenue at $1.1 million for Q3 2020, up 49.18% from a year ago — trailing twelve months through Sep 2020 was $1.1 million (up 49.18% YoY), and the annual figure for FY2019 was $1.0 million, up 678.46%.
  • Non-Current Deffered Revenue for Q3 2020 was $1.1 million at Organogenesis Holdings, roughly flat from $1.1 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for ORGO hit a ceiling of $10.8 million in Q4 2016 and a floor of $74000.0 in Q4 2017.
  • Median Non-Current Deffered Revenue over the past 5 years was $1.1 million (2020), compared with a mean of $4.8 million.
  • Biggest five-year swings in Non-Current Deffered Revenue: tumbled 99.32% in 2017 and later surged 678.46% in 2019.
  • Organogenesis Holdings' Non-Current Deffered Revenue stood at $10.8 million in 2016, then tumbled by 99.32% to $74000.0 in 2017, then soared by 75.68% to $130000.0 in 2018, then surged by 678.46% to $1.0 million in 2019, then rose by 8.5% to $1.1 million in 2020.
  • The last three reported values for Non-Current Deffered Revenue were $1.1 million (Q3 2020), $1.1 million (Q2 2020), and $1.1 million (Q1 2020) per Business Quant data.